Disrupted circadian rhythms in a mouse model of schizophrenia

Current Biology

Volumn 22, Issue 4, 2012, Pages 314-319

  Oliver, Peter L ^a   Sobczyk, Melanie V ^b   Maywood, Elizabeth S ^c   Edwards, Benjamin ^a   Lee, Sheena ^a   Livieratos, Achilleas ^a   Oster, Henrik ^d   Butler, Rachel ^b   Godinho, Sofia I H ^b   Wulff, Katharina ^b   Peirson, Stuart N ^b   Fisher, Simon P ^b,f   Chesham, Johanna E ^c   Smith, Janice W ^e,g   Hastings, Michael H ^c   Davies, Kay E ^a   Foster, Russell G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^e ELI LILLY AND COMPANY   (United States)

^f SRI INTERNATIONAL   (United States)

^g GRÜNENTHAL GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 84862813314     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2011.12.051     Document Type: Article

References (40)

1. K. Wulff, K. Porcheret, E. Cussans, and R.G. Foster Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes Curr. Opin. Genet. Dev. 19 2009 237 246
2. S. Ruhrmann, F. Schultze-Lutter, R.K. Salokangas, M. Heinimaa, D. Linszen, P. Dingemans, M. Birchwood, P. Patterson, G. Juckel, and A. Heinz Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study Arch. Gen. Psychiatry 67 2010 241 251
3. A.F. Jeans, P.L. Oliver, R. Johnson, M. Capogna, J. Vikman, Z. Molnár, A. Babbs, C.J. Partridge, A. Salehi, and M. Bengtsson A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse Proc. Natl. Acad. Sci. USA 104 2007 2431 2436
4. P.L. Oliver, and K.E. Davies Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk Hum. Mol. Genet. 18 2009 4576 4589
5. L.S. Carroll, K. Kendall, M.C. O'Donovan, M.J. Owen, and N.M. Williams Evidence that putative ADHD low risk alleles at SNAP25 may increase the risk of schizophrenia Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B 2009 893 899
6. A.H. Fanous, Z. Zhao, E.J. van den Oord, B.S. Maher, D.L. Thiselton, S.E. Bergen, B. Wormley, T. Bigdeli, R.L. Amdur, and F.A. O'Neill Association study of SNAP25 and schizophrenia in Irish family and case-control samples Am. J. Med. Genet. B. Neuropsychiatr. Genet. 153B 2010 663 674
7. C.M. Lewis, D.F. Levinson, L.H. Wise, L.E. DeLisi, R.E. Straub, I. Hovatta, N.M. Williams, S.G. Schwab, A.E. Pulver, and S.V. Faraone Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia Am. J. Hum. Genet. 73 2003 34 48
8. T. Arinami, T. Ohtsuki, H. Ishiguro, H. Ujike, Y. Tanaka, Y. Morita, M. Mineta, M. Takeichi, S. Yamada, A. Imamura Japanese Schizophrenia Sib-Pair Linkage Group Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p Am. J. Hum. Genet. 77 2005 937 944
9. P.M. Thompson, S. Egbufoama, and M.P. Vawter SNAP-25 reduction in the hippocampus of patients with schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 411 417
10. P.M. Thompson, M. Kelley, J. Yao, G. Tsai, and D.P. van Kammen Elevated cerebrospinal fluid SNAP-25 in schizophrenia Biol. Psychiatry 53 2003 1132 1137
11. S.H. Fatemi, J.A. Earle, J.M. Stary, S. Lee, and J. Sedgewick Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia Neuroreport 12 2001 3257 3262
12. R.D. Johnson, P.L. Oliver, and K.E. Davies SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses Acta Biochim. Pol. 55 2008 619 628
13. I. Spellmann, N. Müller, R. Musil, P. Zill, A. Douhet, S. Dehning, A. Cerovecki, B. Bondy, H.J. Möller, and M. Riedel Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics Eur. Arch. Psychiatry Clin. Neurosci. 258 2008 335 344
14. C.E. Young, K. Arima, J. Xie, L. Hu, T.G. Beach, P. Falkai, and W.G. Honer SNAP-25 deficit and hippocampal connectivity in schizophrenia Cereb. Cortex 8 1998 261 268
15. D.J. Müller, T.A. Klempan, V. De Luca, T. Sicard, J. Volavka, P. Czobor, B.B. Sheitman, J.P. Lindenmayer, L. Citrome, and J.P. McEvoy The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia Neurosci. Lett. 379 2005 81 89
16. V.E. Barakauskas, C.L. Beasley, A.M. Barr, A.R. Ypsilanti, H.Y. Li, A.E. Thornton, H. Wong, G. Rosokilja, J.J. Mann, and B. Mancevski A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia Neuropsychopharmacology 35 2010 1226 1238
17. K. Wulff, E. Joyce, B. Middleton, D.J. Dijk, and R.G. Foster The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report Chronobiol. Int. 23 2006 485 495
18. J. Martin, D.V. Jeste, M.P. Caliguiri, T. Patterson, R. Heaton, and S. Ancoli-Israel Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients Schizophr. Res. 47 2001 77 86
19. J.L. Martin, D.V. Jeste, and S. Ancoli-Israel Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects J. Psychiatr. Res. 39 2005 251 259
20. K. Wulff, D.J. Dijk, B. Middleton, R.G. Foster, and E. Joyce Sleep and circadian dysruption in schizophrenia patients Br. J. Psychiatry 2011 in press
21. S.P. Fisher, S.I. Godinho, C.A. Pothecary, M.W. Hankins, R.G. Foster, and S.N. Peirson Rapid assessment of sleep/wake behaviour in mice J. Biol. Rhythms 2011 in press
22. V. Reghunandanan, and R. Reghunandanan Neurotransmitters of the suprachiasmatic nuclei J. Circadian Rhythms 4 2006 2
23. C.S. Colwell Linking neural activity and molecular oscillations in the SCN Nat. Rev. Neurosci. 12 2011 553 569
24. T. Dickmeis Glucocorticoids and the circadian clock J. Endocrinol. 200 2009 3 22
25. C.L. Waites, and C.C. Garner Presynaptic function in health and disease Trends Neurosci. 34 2011 326 337
26. K.E. Stephan, T. Baldeweg, and K.J. Friston Synaptic plasticity and dysconnection in schizophrenia Biol. Psychiatry 59 2006 929 939
27. S. Panda, M.P. Antoch, B.H. Miller, A.I. Su, A.B. Schook, M. Straume, P.G. Schultz, S.A. Kay, J.S. Takahashi, and J.B. Hogenesch Coordinated transcription of key pathways in the mouse by the circadian clock Cell 109 2002 307 320
28. M.J. Deery, E.S. Maywood, J.E. Chesham, M. Sládek, N.A. Karp, E.W. Green, P.D. Charles, A.B. Reddy, C.P. Kyriacou, K.S. Lilley, and M.H. Hastings Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock Curr. Biol. 19 2009 2031 2036
29. V.E. Golimbet, M.V. Alfimova, I.K. Gritsenko, T.V. Lezheiko, O.M. Lavrushina, L.I. Abramova, V.G. Kaleda, A.N. Barkhatova, A.V. Sokolov, and R.P. Ebstein Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects Neurosci. Behav. Physiol. 40 2010 461 465
30. I. Corradini, C. Verderio, M. Sala, M.C. Wilson, and M. Matteoli SNAP-25 in neuropsychiatric disorders Ann. N Y Acad. Sci. 1152 2009 93 99
31. M.V. Pletnikov, Y. Ayhan, O. Nikolskaia, Y. Xu, M.V. Ovanesov, H. Huang, S. Mori, T.H. Moran, and C.A. Ross Inducible expression of mutant human Dros. Inf. Serv.C1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia Mol Psychiatry 13 2008 173 186
32. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci. 31 2008 234 242
33. A.J. Bradley, and T.G. Dinan A systematic review of hypothalamic- pituitary-adrenal axis function in schizophrenia: implications for mortality J. Psychopharmacol. (Oxford) 24 4, Suppl 2010 91 118
34. A. Balsalobre, S.A. Brown, L. Marcacci, F. Tronche, C. Kellendonk, H.M. Reichardt, G. Schütz, and U. Schibler Resetting of circadian time in peripheral tissues by glucocorticoid signaling Science 289 2000 2344 2347
35. R.J. Hempel, J.H. Tulen, N.J. van Beveren, C.H. Röder, F.H. de Jong, and M.W. Hengeveld Diurnal cortisol patterns of young male patients with schizophrenia Psychiatry Clin. Neurosci. 64 2010 548 554
36. D. Feifel, P.D. Shilling, and G. Melendez Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy J. Psychopharmacol. (Oxford) 25 2011 836 841
37. R. Cáceda, B. Kinkead, and C.B. Nemeroff Neurotensin: role in psychiatric and neurological diseases Peptides 27 2006 2385 2404
38. D. De Wied, and H.O. Sigling Neuropeptides involved in the pathophysiology of schizophrenia and major depression Neurotox. Res. 4 2002 453 468
39. A. Meyer-Lindenberg, G. Domes, P. Kirsch, and M. Heinrichs Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine Nat. Rev. Neurosci. 12 2011 524 538
40. B. Kinkead, and C.B. Nemeroff Novel treatments of schizophrenia: targeting the neurotensin system CNS Neurol. Disord. Drug Targets 5 2006 205 218